Protein kinase C regulation of 12-lipoxygenase-mediated human platelet activation

Molecular Pharmacology

Volumn 81, Issue 3, 2012, Pages 420-430

  Yeung, Jennifer ^a   Apopa, Patrick L ^a   Vesci, Joanne ^a   Kenyon, Victor ^b   Rai, Ganesha ^c   Jadhav, Ajit ^c   Simeonov, Anton ^c   Holman, Theodore R ^b   Maloney, David J ^c   Boutaud, Olivier ^d   Holinstat, Michael ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; ARACHIDONATE 12 LIPOXYGENASE; BAICALEIN; CALCIUM; ENZYME INHIBITOR; INTEGRIN; N [(8 HYDROXY 5 NITROQUINOLIN 7 YL)(THIOPHEN 2 YL)METHYL]PROPIONAMIDE; NCTT 956; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ARACHIDONATE 12-LIPOXYGENASE; BLOOD PLATELETS; BLOTTING, WESTERN; CALCIUM; ENZYME ACTIVATION; FLOW CYTOMETRY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LIPOXYGENASE INHIBITORS; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS;

EID: 84857435608     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.111.075630     Document Type: Article

References (41)

1. Aharony D, Smith JB, and Silver MJ (1982) Regulation of arachidonate-induced platelet aggregation by the lipoxygenase product, 12-hydroperoxyeicosatetraenoic acid. Biochim Biophys Acta 718:193-200. (Pubitemid 13199615)
2. Borsch-Haubold AG, Kramer RM, and Watson SP (1996) Inhibition of mitogenactivated protein kinase kinase does not impair primary activation of human platelets. Biochem J 318 (Pt 1):207-212. (Pubitemid 26283647)
3. Brash AR (1985) A review of possible roles of the platelet 12-lipoxygenase. Circulation 72:702-707.
4. Bugaud F, Nadal-Wollbold F, Lévy-Toledano S, Rosa JP, and Bryckaert M (1999) Regulation of c-jun-NH2 terminal kinase and extracellular-signal regulated kinase in human platelets. Blood 94:3800-3805.
5. Chang J, Blazek E, Kreft AF, and Lewis AJ (1985) Inhibition of platelet and neutrophil phospholipase A2 by hydroxyeicosatetraenoic acids (HETES). A novel pharmacological mechanism for regulating free fatty acid release. Biochem Pharmacol 34:1571-1575. (Pubitemid 15025799)
6. Chari R, Getz T, Nagy B Jr, Bhavaraju K, Mao Y, Bynagari YS, Murugappan S, Nakayama K, and Kunapuli SP (2009) Protein kinase Cδ differentially regulates platelet functional responses. Arterioscler Thromb Vasc Biol 29:699-705.
7. Chen FL, Wang XZ, Li JY, Yu JP, Huang CY, and Chen ZX (2008) 12-Lipoxygenase induces apoptosis of human gastric cancer AGS cells via the ERK1/2 signal pathway. Dig Dis Sci 53:181-187.
8. Deschamps JD, Kenyon VA, and Holman TR(2006) Baicalein is a potent in vitro inhibitor against both reticulocyte 15-human and platelet 12-human lipoxygenases. Bioorg Med Chem 14:4295-4301.
9. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ, and MATCH investigators(2004) Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 364:331-337.
10. Ding XZ, Tong WG, and Adrian TE (2001) 12-Lipoxygenase metabolite 12(S)-HETE stimulates human pancreatic cancer cell proliferation via protein tyrosine phosphorylation and ERK activation. Int J Cancer 94:630-636.
11. Durand-Zaleski I and Bertrand M (2004) The value of clopidogrel versus aspirin in reducing atherothrombotic events: the CAPRIE study. Pharmacoeconomics 22 (Suppl 4):19-27. (Pubitemid 40066090)
12. Fälker K, Haglund L, Gunnarsson P, Nylander M, Lindahl TL, and Grenegård M2011) Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets. Biochem J 436:469-480.
13. Grabarek J and Ware JA (1993) Protein kinase C activation without membrane contact in platelets stimulated by bryostatin. J Biol Chem 268:5543-5549. (Pubitemid 23090875)
14. Gurbel PA, Tantry US, Shuldiner AR, and Kereiakes DJ (2010) Genotyping: one piece of the puzzle to personalize antiplatelet therapy. J Am Coll Cardiol 56:112-116.
15. Harper MT and Poole AW (2010) Diverse functions of protein kinase C isoforms in platelet activation and thrombus formation. J Thromb Haemost 8:454-462.
16. Holinstat M, Boutaud O, Apopa PL, Vesci J, Bala M, Oates JA, and Hamm HE (2011) Protease-activated receptor signaling in platelets activates cytosolic phospholipase A2α differently for cyclooxygenase-1 and 12-lipoxygenase catalysis. Arterioscler Thromb Vasc Biol 31:435-442.
17. Kenyon V, Rai G, Jadhav A, Schultz L, Armstrong M, Jameson JB 2nd, Perry S, Joshi N, Bougie JM, Leister W, et al. (2011) Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase. J Med Chem 54:5485-5497.
18. Khan WA, Blobe G, Halpern A, Taylor W, Wetsel WC, Burns D, Loomis C, and Hannun YA (1993) Selective regulation of protein kinase C isoenzymes by oleic acid in human platelets. J Biol Chem 268:5063-5068. (Pubitemid 23081631)
19. Kim SY, Kim S, Kim JM, Jho EH, Park S, Oh D, and Yun-Choi HS (2011) PKC inhibitors RO 31-8220 and Go 6983 enhance epinephrine-induced platelet aggregation in catecholamine hypo-responsive platelets by enhancing Akt phosphorylation. BMB Rep 44:140-145.
20. Konopatskaya O, Gilio K, Harper MT, Zhao Y, Cosemans JM, Karim ZA, Whiteheart SW, Molkentin JD, Verkade P, Watson SP, et al. (2009) PKCα regulates platelet granule secretion and thrombus formation in mice. J Clin Invest 119:399-407.
21. Konopatskaya O and Poole AW (2010) Protein kinase Cα: disease regulator and therapeutic target. Trends Pharmacol Sci 31:8-14.
22. Kramer RM, Roberts EF, Strifler BA, and Johnstone EM (1995) Thrombin induces activation of p38 MAP kinase in human platelets. J Biol Chem 270:27395-27398.
23. Lee SH, Williams MV, DuBois RN, and Blair IA (2003) Targeted lipidomics using electron capture atmospheric pressure chemical ionization mass spectrometry. Rapid Commun Mass Spectrom 17:2168-2176. (Pubitemid 37203705)
24. Liu B, Khan WA, Hannun YA, Timar J, Taylor JD, Lundy S, Butovich I, and Honn KV (1995) 12(S)-Hydroxyeicosatetraenoic acid and 13(S)- hydroxyoctadecadienoic acid regulation of protein kinase C-α in melanoma cells: role of receptor-mediated hydrolysis of inositol phospholipids. Proc Natl Acad Sci USA 92:9323-9327.
25. Mahanonda N (1998) Anti-thrombotic and anticoagulant treatment in interventional cardiology. J Med Assoc Thai 81:42-46.
26. McPhail LC, Clayton CC, and Snyderman R (1984) A potential second messenger role for unsaturated fatty acids: activation of Ca2+ -dependent protein kinase. Science 224:622-625. (Pubitemid 14137535)
27. Nadal-Wollbold F, Pawlowski M, Lévy-Toledano S, Berrou E, Rosa JP, and Bryckaert M (2002) Platelet ERK2 activation by thrombin is dependent on calcium and conventional protein kinases C but not Raf-1 or B-Raf. FEBS Lett 531:475-482. (Pubitemid 35336072)
28. Nyby MD, Sasaki M, Ideguchi Y, Wynne HE, Hori MT, Berger ME, Golub MS, Brickman AS, and Tuck ML (1996) Platelet lipoxygenase inhibitors attenuatethrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation. J Pharmacol Exp Ther 278:503-509. (Pubitemid 27167012)
29. Patrono C, García Rodríguez LA, Landolfi R, and Baigent C (2005) Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 353:2373-2383. (Pubitemid 41713749)
30. Pidgeon GP, Lysaght J, Krishnamoorthy S, Reynolds JV, O'Byrne K, Nie D, and Honn KV (2007) Lipoxygenase metabolism: roles in tumor progression and survival. Cancer Metastasis Rev 26:503-524. (Pubitemid 350115127)
31. 3 integrin signaling involves 12-lipoxygenase- and PKC-mediated serine phosphorylation events in melanoma cells. Thromb Haemost 85:1037-1042.
32. Reed KA, Tucker DE, Aloulou A, Adler D, Ghomashchi F, Gelb MH, Leslie CC, Oates JA, and Boutaud O (2011) Functional characterization of mutations in inherited human cPLA2 deficiency. Biochemistry 50:1731-1738.
33. Samiei M, Sanghera JS, and Pelech SL (1993) Activation of myelin basic protein and S6 peptide kinases in phorbol ester- and PAF-treated sheep platelets. Biochim Biophys Acta 1176:287-298. (Pubitemid 23113771)
34. Seth RK, Haque MS, and Zelenka PS (2001) Regulation of c-fos induction in lens epithelial cells by 12(S)HETE-dependent activation of PKC. Invest Ophthalmol Vis Sci 42:3239-3246. (Pubitemid 33740686)
35. Shearman MS, Naor Z, Sekiguchi K, Kishimoto A, and Nishizuka Y (1989) Selective activation of the γ-subspecies of protein kinase C from bovine cerebellum by arachidonic acid and its lipoxygenase metabolites. FEBS Lett 243:177-182. (Pubitemid 19037476)
36. Strehl A, Munnix IC, Kuijpers MJ, van der Meijden PE, Cosemans JM, Feijge MA, Nieswandt B, and Heemskerk JW (2007) Dual role of platelet protein kinase C in thrombus formation: stimulation of pro-aggregatory and suppression of procoagulant activity in platelets. J Biol Chem 282:7046-7055. (Pubitemid 47093677)
37. Szekeres CK, Tang K, Trikha M, and Honn KV (2000) Eicosanoid activation of extracellular signal-regulated kinase1/2 in human epidermoid carcinoma cells. J Biol Chem 275:38831-38841. (Pubitemid 32009220)
38. Thomas CP, Morgan LT, Maskrey BH, Murphy RC, Kühn H, Hazen SL, Goodall AH, Hamali HA, Collins PW, and O'Donnell VB (2010) Phospholipid- esterified eicosanoids are generated in agonist-activated human platelets and enhance tissue factor-dependent thrombin generation. J Biol Chem 285:6891-6903.
39. 2+. J Biol Chem 286:20173-21082.
40. Varon D and Spectre G (2009) Antiplatelet agents. Hematol Am Soc Hematol Educ Program 267-272.
41. Yacoub D, Théorêt JF, Villeneuve L, Abou-Saleh H, Mourad W, Allen BG, and Merhi Y (2006) Essential role of protein kinase Cδ in platelet signaling, αIIbβ3 activation, and thromboxane A2 release. J Biol Chem 281:30024-30035. (Pubitemid 44537010)